Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocotrienols for Atrial Fibrillation Post-CABG
NCT03807037Phase 3Completed
- Sponsor
- Monash University
- Start
- Dec 2018
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) (2 arms), sponsored by Monash University. Primary endpoint: Incidence of Atrial Fibrillation at 6 weeks. Started Dec 2018; status: completed.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03807037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03807037.